187 related articles for article (PubMed ID: 9640128)
1. Clinical spectrum associated with positive ANCA titres in 94 consecutive patients: is there a relation with PR-3 negative c-ANCA and hypergammaglobulinaemia?
Blockmans D; Stevens E; Mariën G; Bobbaers H
Ann Rheum Dis; 1998 Mar; 57(3):141-5. PubMed ID: 9640128
[TBL] [Abstract][Full Text] [Related]
2. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis].
Csernok E; Reichel P; Gross WL
Z Rheumatol; 2002 Aug; 61(4):367-77. PubMed ID: 12426842
[TBL] [Abstract][Full Text] [Related]
3. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
[TBL] [Abstract][Full Text] [Related]
4. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
[TBL] [Abstract][Full Text] [Related]
5. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
[TBL] [Abstract][Full Text] [Related]
6. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
7. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
[TBL] [Abstract][Full Text] [Related]
8. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis.
Daouk GH; Palsson R; Arnaout MA
Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.
Kallenberg CG; Mulder AH; Tervaert JW
Am J Med; 1992 Dec; 93(6):675-82. PubMed ID: 1466365
[TBL] [Abstract][Full Text] [Related]
11. Incidence and disease associations of a proteinase 3-antineutrophil cytoplasmic antibody idiotype (5/7 Id) whose antiidiotype inhibits proteinase 3-antineutrophil cytoplasmic antibody antigen binding activity.
Strunz HP; Csernok E; Gross WL
Arthritis Rheum; 1997 Jan; 40(1):135-42. PubMed ID: 9008609
[TBL] [Abstract][Full Text] [Related]
12. Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis.
Gisslén K; Wieslander J; Westberg G; Herlitz H
J Intern Med; 2002 Feb; 251(2):129-35. PubMed ID: 11905588
[TBL] [Abstract][Full Text] [Related]
13. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.
Hauer HA; Bajema IM; van Houwelingen HC; Ferrario F; Noël LH; Waldherr R; Jayne DR; Rasmussen N; Bruijn JA; Hagen EC;
Kidney Int; 2002 Jan; 61(1):80-9. PubMed ID: 11786087
[TBL] [Abstract][Full Text] [Related]
14. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
15. p-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvement.
Dringenberg C; Apenberg S; Andrassy K
Adv Exp Med Biol; 1993; 336():445-7. PubMed ID: 8296653
[TBL] [Abstract][Full Text] [Related]
16. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
Dolman KM; Stegeman CA; van de Wiel BA; Hack CE; von dem Borne AE; Kallenberg CG; Goldschmeding R
Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.
Schönermarck U; Lamprecht P; Csernok E; Gross WL
Rheumatology (Oxford); 2001 Feb; 40(2):178-84. PubMed ID: 11257154
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis.
Brockmann H; Schwarting A; Kriegsmann J; Petrow P; Gaumann A; Müller KM; Galle PR; Mayet W
Arthritis Res; 2002; 4(3):220-5. PubMed ID: 12010574
[TBL] [Abstract][Full Text] [Related]
19. p-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy.
Rump JA; Wörner I; Roth M; Schölmerich J; Hänsch M; Peter HH
Adv Exp Med Biol; 1993; 336():507-13. PubMed ID: 8296665
[TBL] [Abstract][Full Text] [Related]
20. In vitro interactions of c-ANCA (antibodies to proteinase 3) with human endothelial cells.
Mayet WJ; Hermann EM; Csernok E; Gross WL; Meyer zum Büschenfelde KH
Adv Exp Med Biol; 1993; 336():109-13. PubMed ID: 8296598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
